{"id":789,"date":"2013-02-26T12:43:13","date_gmt":"2013-02-26T12:43:13","guid":{"rendered":"https:\/\/www.billingparadise.com\/blog\/?p=789"},"modified":"2022-06-06T02:49:14","modified_gmt":"2022-06-06T07:49:14","slug":"to-keep-or-not-to-keep-that-is-the-question-the-sunshine-act-poses-to-physicians","status":"publish","type":"post","link":"https:\/\/www.billingparadise.com\/blog\/to-keep-or-not-to-keep-that-is-the-question-the-sunshine-act-poses-to-physicians\/","title":{"rendered":"To Keep or Not to Keep, that is the Question the Sunshine Act Poses to Physicians"},"content":{"rendered":"<p style=\"text-align: justify;\"><b>No Escape For Physicians Under This Sunshine<\/b><\/p>\n<p style=\"text-align: justify;\">After much deliberation involving multitude of responses to the proposed rule, the <i>final rule <\/i>to the <span style=\"color: #ff6600;\">Sunshine Act of 2010 was ultimately published on Feb 1, 2013.<\/span> \u00a0\u00a0This <i>finally<\/i> put an end to all speculation, as to whether receiving small tokens of appreciation from a drug or device manufacturer will affect the decision making of a physician, and whether the patient needed to know about the same.<\/p>\n<p style=\"text-align: justify;\">CMS has answered in the affirmative, that \u201cyes\u201d, any such transfers of value exceeding $10 ought to be disclosed by the drug or device manufacturer, and the patient has a right to know about this particular arrangement.\u00a0 <span style=\"color: #ff6600;\">Also, needless to say, if the <span style=\"color: #ff6600;\">physician<\/span> or his\/her acquaintance has an interest in the drug company, that ought to be disclosed to CMS as well.<\/span><\/p>\n<p style=\"text-align: justify;\"><b>A Comedy of Disclosures<\/b><\/p>\n<p style=\"text-align: justify;\">Although the act does not prohibit payments, it is a mandatory disclosure statute.\u00a0 The act tries to use some ambivalent legalese to drive home its point, that may ultimately leave some of the physicians confused as to what it denotes as \u201capplicable manufacturers\u201d, \u201ccovered products\u201d or \u201ccovered recipients\u201d.<\/p>\n<p style=\"text-align: justify;\">And it does not cease there, there are four different items under \u201ctransfers of value\u201d and 15 entities under reportable payment categories.\u00a0 Then there is the rule about gifts being smaller $10 but still reportable if the total value exceeded $100 in a year.\u00a0 All of these motley criteria might most probably end up befuddling a practitioner and make him question:\u00a0 <strong><span style=\"color: #ff6600;\">WHY?????????????<\/span><\/strong><\/p>\n<p style=\"text-align: justify;\">But as the CMS website says, this probably is a good turn of event in the cause for greater transparency in the healthcare system.<\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #ff6600;\">\u201c<i>a final rule that will increase public awareness of financial relationships between drug and device manufacturers and certain health care providers. Called the \u201cNational <span style=\"color: #ff6600;\">Physician Payment Transparency Program<\/span>: Open Payments,\u201d this is one of many steps in the Affordable Care Act designed to create greater transparency in the health care market.\u201d<\/i><\/span><\/p>\n<p style=\"text-align: justify;\">So the next time your drug or device company executive calls you up wondering what you ate at their last conference, drop that incredulous look from your face and find out from your <i>virtual personal assistant <\/i>your preferred meal on a holiday!!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>No Escape For Physicians Under This Sunshine After much deliberation involving multitude of responses to the proposed rule, the final rule to the Sunshine Act of 2010 was ultimately published on Feb 1, 2013. \u00a0\u00a0This finally put an end to all speculation, as to whether receiving small tokens of appreciation from a drug or device [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":792,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[743],"tags":[],"class_list":["post-789","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-practice-management"],"modified_by":"Erika Regulsky","_links":{"self":[{"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/posts\/789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/comments?post=789"}],"version-history":[{"count":0,"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/posts\/789\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/media\/792"}],"wp:attachment":[{"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/media?parent=789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/categories?post=789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.billingparadise.com\/blog\/wp-json\/wp\/v2\/tags?post=789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}